| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA406408
Max Phase: Preclinical
Molecular Formula: C25H23ClN4O3
Molecular Weight: 462.94
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: CCNC(=O)n1cc(Cn2c(C(=O)CC)c(-c3ccccc3)c3cc(Cl)ccc3c2=O)cn1
Standard InChI: InChI=1S/C25H23ClN4O3/c1-3-21(31)23-22(17-8-6-5-7-9-17)20-12-18(26)10-11-19(20)24(32)29(23)14-16-13-28-30(15-16)25(33)27-4-2/h5-13,15H,3-4,14H2,1-2H3,(H,27,33)
Standard InChI Key: SITHVWUDPUFZQO-UHFFFAOYSA-N
Associated Targets(Human)
c-Jun N-terminal kinase 1 5038 Activities
Associated Targets(non-human)
Mitogen-activated protein kinase 8 32 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 462.94 | Molecular Weight (Monoisotopic): 462.1459 | AlogP: 4.74 | #Rotatable Bonds: 6 |
| Polar Surface Area: 85.99 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 1 |
| #RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: | CX Basic pKa: | CX LogP: 3.84 | CX LogD: 3.84 |
| Aromatic Rings: 4 | Heavy Atoms: 33 | QED Weighted: 0.42 | Np Likeness Score: -1.09 |
References
| 1. Asano Y, Kitamura S, Ohra T, Itoh F, Kajino M, Tamura T, Kaneko M, Ikeda S, Igata H, Kawamoto T, Sogabe S, Matsumoto S, Tanaka T, Yamaguchi M, Kimura H, Fukumoto S.. (2008) Discovery, synthesis and biological evaluation of isoquinolones as novel and highly selective JNK inhibitors (2)., 16 (8): [PMID:18313930] [10.1016/j.bmc.2008.02.028] |
Source
Source(1):